Metraipolis › archive › dc_cbc8cd89e488

Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection — Europe PMC PMID:42459676

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42459676
DOI: 10.3389/fimmu.2026.1775386
License (as archived): solo-consultazione
Archived: 2026-10-18T12:18:36.483Z
SHA-256 of the archived text: f2f605a59fd0e54484c394808e5a92e8b64fac1bb7f53f9d5b13c2e2fe0053f6
Stable URL of this page: https://metraipolis.com/documento/dc_cbc8cd89e488

How to cite

Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection — Europe PMC PMID:42459676 — Europe PMC (en), https://europepmc.org/article/MED/42459676 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cbc8cd89e488 (Metraipolis archive dc_cbc8cd89e488, sha256 f2f605a59fd0e54484c394808e5a92e8b64fac1bb7f53f9d5b13c2e2fe0053f6)

BibTeX

@misc{dccbc8cd89e488,
  title = {Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection — Europe PMC PMID:42459676},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42459676},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cbc8cd89e488; sha256 f2f605a59fd0e54484c394808e5a92e8b64fac1bb7f53f9d5b13c2e2fe0053f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42459676. Agents can read the archived copy with the MCP tool read_document.